Therapeutic Vaccines for HPV-Associated Malignancies
Claire Smalley Rumfield, Nicholas Roller, Samuel Troy Pellom, Jeffrey Schlom,* Caroline Jochems* Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA*These authors contributed equally to this workCorrespon...
Main Authors: | Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | ImmunoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/therapeutic-vaccines-for-hpv-associated-malignancies-peer-reviewed-article-ITT |
Similar Items
-
HPV Positive Status Is a Favorable Prognostic Factor in Non-Nasopharyngeal Head and Neck Squamous Cell Carcinoma Patients: A Retrospective Study From the Surveillance, Epidemiology, and End Results Database
by: Qiuji Wu, et al.
Published: (2021-09-01) -
CX-4945 and siRNA-Mediated Knockdown of CK2 Improves Cisplatin Response in HPV(+) and HPV(−) HNSCC Cell Lines
by: Janeen H. Trembley, et al.
Published: (2021-05-01) -
Distinguishable Prognostic miRNA Signatures of Head and Neck Squamous Cell Cancer With or Without HPV Infection
by: Xiao-jie Luo, et al.
Published: (2021-02-01) -
Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects
by: Mine Özcan-Wahlbrink, et al.
Published: (2019-12-01) -
PAPILLOMAVIRUSES: HPV AS THE ETIOLOGICAL FACTOR OF HEAD AND NECK CANCERS
by: Michał Wiciński, Kamil Leis, et al.
Published: (2018-06-01)